Form 8-K - Current report:
SEC Accession No. 0001193125-21-193199
Filing Date
2021-06-17
Accepted
2021-06-17 16:16:28
Documents
15
Period of Report
2021-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d165256d8k.htm   iXBRL 8-K 28957
2 EX-99.1 d165256dex991.htm EX-99.1 14410
6 GRAPHIC g165256g10k36.jpg GRAPHIC 2917
7 GRAPHIC g165256g50i63.jpg GRAPHIC 2458
  Complete submission text file 0001193125-21-193199.txt   183558

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210617.xsd EX-101.SCH 3070
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210617_lab.xml EX-101.LAB 18908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210617_pre.xml EX-101.PRE 11863
8 EXTRACTED XBRL INSTANCE DOCUMENT d165256d8k_htm.xml XML 3514
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 211024955
SIC: 2834 Pharmaceutical Preparations